NATTOKINASE DEGRADES THE SPIKE PROTEIN OF SARS COV2
in this way inhibits the entry of the virus into host cells
So in addition to using it as a Fibrinolytic, Anticoagulant,Antiplatelet
is added this effect against Viral Load of #Nattokinase doi.org/10.3390/molecu… #LongCovid#CFS
There are several other studies of the use of NATTOKINASE
In the link is a study that included 153patients with deep vein thrombosis,phlebitis or venous insufficiency
Conclude that NK represents an efficient/safe treatment in patien. with vascular diseases doi.org/10.3390/nu1306…
In this study
they point out that Nattokinase was superior in safety to t-PA, which is a traditional thrombolytic for IV use
A lower risk of bleeding was observed with the use of NK
And they conclude that NK is an excellent antithrombotic and with low risk doi.org/10.1007/s10068…
• • •
Missing some Tweet in this thread? You can try to
force a refresh
Viral persistence has already been sufficiently demonstrated
It was simple for us to do it since April2020
They should no longer spend on studies that do not provide solutions
There are several Antivirals
These studies are postponed
&DrugResistance advance
A LOW LEVEL OF OXYGEN IN THE MUSCLES
(HYPOXIA)
IS THE MOST FREQUENT CAUSE OF
CHRONIC FATIGUE
POST-EXERTIONAL MALAISE:PEM
NON-RESTORATIVE SLEEP
MUSCULOSKELETAL STIFFNESS AND PAIN WHEN WAKING UP
Histamine causes greater endothelial damage in COVID
by increasing the number of complement C3/C3b binding sites
on the surface of endothelial cells
This
is one more support for our Antihistamine Protocols
before starting Antivirals
This study included Biopsies of endothelial tissue and thrombotic clots
Fig.4 shows SARS CoV2 (light circles)
inside clots adhered to infected endothelial cells
It confirms what we graphed almost 3years ago
and we call them BIOCLOTS mdpi.com/2075-1729/14/2…
It will still take years
for it to be accepted that Microclots
serve as a protective barrier
for viruses and other microorganisms to persist
This occurs in several chronic diseases
They are diseases based on Biofilms & Reservoirs
with persistent infections
Most of the symptoms of LongCOVID
they are associated with Hypoperfusion, Hipercoagulability & Microclots (HHM)
because it is a Persistent Infectious Disease that affects the blood vessels
The second most common cause of LongCOVID symptoms is Histaminosis
STUDY BASED ON BIOPSIES SHOWS IN SITU PRESENCE OF SARS COV-2
IN ENDOTHELIAL CELLS AND CLOTS
Findings support our Protocols established since 2020
The main thing is to reduce the VIRAL LOAD
Anticoagulant & Antiplatelet Therapy does not go against the CAUSE mdpi.com/2075-1729/14/2…
If there are Persistent Microclots
so
there is a Persistent Infection
which is the main CAUSE to treat
The patient may spend years taking Anticoagulants/Antiplatelets
while
with a Protocol with 3-6 Antivirals the patient can recover in days or a few months